Mullen James C
CIK 0001226288
CEODirector
Filings
6
Latest May 22, 2025
Issuers covered
2
Showing
6 of 6
Page 1
Track record
1 of 1 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 1 | 100% | +34.1% | +34.1% | +34.1% | +34.1% |
| 90 days | 1 | 100% | +22.7% | +22.7% | +22.7% | +22.7% |
| 180 days | 1 | 100% | +47.3% | +47.3% | +47.3% | +47.3% |
| 365 days | 1 | 100% | +69.5% | +69.5% | +69.5% | +69.5% |
Issuers
Companies where Mullen James C has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| TMO | Thermo Fisher Scientific Inc. | 4 | May 22, 2025 |
| EDIT | Editas Medicine, Inc. | 2 | Apr 18, 2022 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|